ImmunologybioRxivPreprint
Anti-SARS-CoV-2 swine glyco-humanized polyclonal antibody XAV-19 retains neutralizing activity against SARS-CoV-2 B.1.1.529 (Omicron)
DOI 10.1101/2022.01.26.477856
Author
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
3 papers
Recent·Most cited
B. Vanhove, S. S. Marot, R. So…·V. Calvez
XAV-19, a swine glyco-humanized polyclonal antibody against SARS-CoV-2 Spike RBD, neutralizes multiple variants by targeting multiple epitopes and shows potential in clinical trials.
S. S. Marot, I. Malet, A. Jary…·A.-G. Marcelin
The study assesses neutralizing antibody potency against UK and SA SARS-CoV-2 variants in vaccinated and convalescent healthcare workers, finding reduced neutralization against SA variants in some convalescents.